Quality Systems

Cynthia A. Challener is a contributing editor to Pharmaceutical Technology.

Articles

Production of viral vectors requires a holistic view of the product, including its manufacturing process and its ultimate end use.

Testing for Adventitious Agents in Viral Vector Production

Pramote Cholayudth previously was the managing director of the Professional Conference Center, Ltd. He currently is a validation consultant to Biolab Co., Ltd., in Thailand. He is the founder and manager of PM consult, cpramote2000@yahoo.com.

This article introduces a control chart technique using F statistic for continued process verification of oral solid dosage forms.

Application of F Charts in Continued Process Verification of OSD Forms

Hamish Hogg is microbiology product specialist at Cherwell Laboratories.

A blended approach to newly revised regulatory guidance to inform environmental monitoring programmes is essential.

The Future of Pharmaceutical Environmental Monitoring in Europe

Bianca Piachaud-Moustakis is lead writer at Pharmavision, Pharmavision.co.uk.

Under the revised NIS-2 Directive in Europe, pharma companies will need to be proactive in safeguarding their digital assets.

Securing Europe’s Critical Entities from Cyber Attacks

Jill Wechsler is Pharmaceutical Technology's Washington Editor, jillwechsler7@gmail.com.

FDA backs joint reviews, common research policies, and modern production methods around the world.

Advancing Global Collaboration for Drug Testing, Regulation, and Manufacturing

Susan J. Schniepp is a fellow at Regulatory Compliance Associates, Inc. and a member of Pharmaceutical Technology's Editorial Advisory Board.

Susan J. Schniepp, distinguished fellow at Regulatory Compliance Associates, addresses the difference between regulatory compliance and real compliance.

Regulatory Compliance Versus Real Compliance

Detlev Lennartz, Sample Handling Product Manager, Thermo Fisher Scientific.

Choosing low-adsorption glass vials helps ensure detection accuracy.

High-Quality Glass Improves Confidence in Analytes Measurement

Julie Lippke, analytical research and development at Pfizer Inc., Groton, CT

Joseph Mongillo, analytical research and development at Pfizer Inc., Groton, CT

Thomas Cullen, analytical research and development, AbbVie Inc., North Chicago, IL

Christian Metz works in Analytical Research and Development at AbbVie Inc., Ludwigshafen, Germany.

Katria Harasewych, quality, Merck & Co., Inc., Kenilworth, NJ

Fouad Benamira works in Analytical Development Sciences for Biologicals at UCB S.A. Belgium.

The IQ Working Group has defined a pragmatic risk-based approach to audit trail review, where it is only required for high impact GxP data.

A Harmonized Approach to Performing a Risk-Based Audit Trail Review

Siegfried Schmitt, PhD, is Vice President Technical at Parexel International, Siegfried.Schmitt@parexel.com.

A process flow diagram can help create an agreed-upon process flow for a third-party standard operating procedure, says Siegfried Schmitt, VP Technical at Parexel. 

Best Practices for Developing a Third-Party Auditing SOP

Pharmaceutical Technology spoke with Andrew Anderson, Global Head Strategic Account Management and Mary Todas, Director Technical Development and Regulatory Affairs, both with Pfizer CentreOne, about best practices for API quality. 

Quality Assurance/Quality Control